A detailed history of Lmcg Investments, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lmcg Investments, LLC holds 23,514 shares of AZN stock, worth $1.57 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
23,514
Previous 40,359 41.74%
Holding current value
$1.57 Million
Previous $3.14 Million 51.02%
% of portfolio
0.1%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

SELL
$63.2 - $79.58 $1.06 Million - $1.34 Million
-16,845 Reduced 41.74%
23,514 $1.54 Million
Q3 2024

Oct 29, 2024

SELL
$76.67 - $87.62 $154,413 - $176,466
-2,014 Reduced 4.75%
40,359 $3.14 Million
Q2 2024

Aug 09, 2024

SELL
$66.81 - $80.83 $15,566 - $18,833
-233 Reduced 0.55%
42,373 $3.3 Million
Q1 2024

May 03, 2024

SELL
$61.03 - $69.57 $127,735 - $145,610
-2,093 Reduced 4.68%
42,606 $2.89 Million
Q4 2023

Feb 07, 2024

SELL
$61.89 - $69.28 $52,854 - $59,165
-854 Reduced 1.87%
44,699 $3.01 Million
Q3 2023

Nov 02, 2023

SELL
$64.85 - $71.7 $139,103 - $153,796
-2,145 Reduced 4.5%
45,553 $3.08 Million
Q2 2023

Aug 02, 2023

SELL
$69.91 - $75.81 $115,141 - $124,859
-1,647 Reduced 3.34%
47,698 $3.41 Million
Q1 2023

May 04, 2023

SELL
$63.15 - $71.6 $21,534 - $24,415
-341 Reduced 0.69%
49,345 $3.43 Million
Q4 2022

Feb 06, 2023

BUY
$54.21 - $70.44 $40,278 - $52,336
743 Added 1.52%
49,686 $3.37 Million
Q3 2022

Nov 07, 2022

BUY
$53.02 - $135.75 $204,816 - $524,402
3,863 Added 8.57%
48,943 $2.68 Million
Q2 2022

Aug 08, 2022

SELL
$59.26 - $71.14 $38,400 - $46,098
-648 Reduced 1.42%
45,080 $2.98 Million
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $2.55 Million - $3.07 Million
45,728 New
45,728 $3.03 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Lmcg Investments, LLC Portfolio

Follow Lmcg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lmcg Investments, LLC with notifications on news.